Skip to main content

04-21-2017 | Prediabetes | News

Metabolic abnormalities associated with cognitive dysfunction


medwireNews: Impaired fasting plasma glucose and insulin resistance are associated with an increased risk for developing cognitive dysfunction among postmenopausal women, results of a Danish study suggest.

In an analysis of data from 1759 participants of the Prospective Epidemiological Risk Factor study, the researchers found that women with impaired fasting plasma glucose (>5.6 mmol/L) at baseline were significantly more likely to have cognitive dysfunction – as measured by a category fluency test with animal naming (CFT) score of 14 points or less – after 15 years of follow-up compared with normoglycemic individuals, with an adjusted odds ratio (OR) of 1.44.

Furthermore, participants with a poor metabolic profile, indicated by the presence of all five components of the metabolic syndrome (body mass index >30 kg/m2, triglycerides >1.7 mmol/L, high density lipoprotein cholesterol <1.29 mmol/L, fasting plasma glucose >5.6 mmol/L, and hypertension), were approximately three times more likely to develop cognitive dysfunction based on CFT scores than those than metabolically normal individuals (OR=3.07).

Those with all five components of the metabolic syndrome were also significantly more likely to develop cognitive dysfunction as measured by a combination of CFT scores and the Short Blessed Test (SBT) – an assessment of orientation, concentration, and memory – than those with no risk factors (OR=4.35).

However, participants with one to four metabolic syndrome components did not have a significantly increased risk for cognitive dysfunction at follow-up.

The researchers also identified an association between insulin resistance and cognition; women with a homeostasis model assessment of insulin resistance (HOMA-IR) index score of more than 2.6 at baseline had a significantly higher risk for cognitive dysfunction based on CFT scores (OR=1.47) compared with those below the threshold.

And when analyzing insulin resistance as a continuous variable, the risk for cognitive dysfunction by CFT and a combination of CFT and SBT increased by a respective 8% and 10% for every unit increase on the HOMA-IR index scale, reports the team in Diabetes.

Jesper Neergaard (Nordic Bioscience A/S, Herlev, Denmark) and colleagues believe that their findings “can be taken to indicate a temporal relation between [insulin resistance] and cognitive dysfunction,” but stress that the observational study design “does not allow for causal conclusions.”

“[Insulin resistance] may be a shared underlying pathological mechanism, since it is part of the prodromal phase of both type 2 diabetes and dementia,” they add.

And the researchers conclude: “If the observed association […] is truly causal it could suggest that a significant proportion of dementia cases in women may be preventable by effective control of insulin homeostasis.”

By Claire Barnard

medwireNews is an independent medical news service provided by Springer Healthcare. © 2017 Springer Healthcare part of the Springer Nature group


Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »